Zhejiang Jianye Chemical Co., Ltd.
SSE:603948.SS
18.27 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,394.258 | 2,649.673 | 2,796.06 | 2,799.5 | 1,728.693 | 1,675.654 | 1,832.163 | 1,820.483 | 1,550.334 | 1,614.72 |
| Cost of Revenue
| 2,064.681 | 2,149.837 | 2,157.488 | 2,299.282 | 1,495.424 | 1,368.655 | 1,458.769 | 1,533.579 | 1,344.074 | 1,440.48 |
| Gross Profit
| 329.577 | 499.836 | 638.573 | 500.217 | 233.268 | 307 | 373.394 | 286.905 | 206.26 | 174.239 |
| Gross Profit Ratio
| 0.138 | 0.189 | 0.228 | 0.179 | 0.135 | 0.183 | 0.204 | 0.158 | 0.133 | 0.108 |
| Reseach & Development Expenses
| 31.184 | 30.477 | 97.628 | 96.212 | 55.963 | 53.996 | 64.148 | 59.359 | 38.097 | 39.126 |
| General & Administrative Expenses
| 22.429 | 80.465 | 26.205 | 21.382 | 19.032 | 16.222 | 25.42 | 27.153 | 44.405 | 39.224 |
| Selling & Marketing Expenses
| 5.176 | 6.374 | 13.342 | 16.501 | 10.014 | 61.074 | 60.806 | 52.945 | 49.995 | 48.615 |
| SG&A
| 27.605 | 88.305 | 39.547 | 37.883 | 29.046 | 77.297 | 86.226 | 80.098 | 94.399 | 87.839 |
| Other Expenses
| 23.589 | 5.01 | 75.192 | 49.924 | 25.013 | 29.971 | 14.295 | 5.675 | 15.001 | 43.565 |
| Operating Expenses
| 82.378 | 123.792 | 212.367 | 184.019 | 110.022 | 161.264 | 182.889 | 174.109 | 138.738 | 130.086 |
| Operating Income
| 247.199 | 376.044 | 447.453 | 323.435 | 127.98 | 151.454 | 210.824 | 199.163 | 50.8 | -8.838 |
| Operating Income Ratio
| 0.103 | 0.142 | 0.16 | 0.116 | 0.074 | 0.09 | 0.115 | 0.109 | 0.033 | -0.005 |
| Total Other Income Expenses Net
| 4.753 | 9.832 | 7.245 | 6.096 | 16.843 | 12.748 | 14.295 | 5.675 | 15.002 | 43.565 |
| Income Before Tax
| 251.953 | 385.876 | 454.698 | 329.531 | 144.823 | 164.201 | 225.119 | 204.838 | 65.801 | 34.727 |
| Income Before Tax Ratio
| 0.105 | 0.146 | 0.163 | 0.118 | 0.084 | 0.098 | 0.123 | 0.113 | 0.042 | 0.022 |
| Income Tax Expense
| 42.896 | 68.192 | 64.459 | 39.509 | 19.137 | 21.668 | 27.567 | 38.075 | 10.455 | 5.294 |
| Net Income
| 209.057 | 317.684 | 390.244 | 290.022 | 125.686 | 142.533 | 197.552 | 166.763 | 55.346 | 29.433 |
| Net Income Ratio
| 0.087 | 0.12 | 0.14 | 0.104 | 0.073 | 0.085 | 0.108 | 0.092 | 0.036 | 0.018 |
| EPS
| 1.29 | 1.98 | 2.44 | 1.81 | 0.79 | 0.89 | 1.65 | 1.39 | 0.46 | 0.25 |
| EPS Diluted
| 1.29 | 1.98 | 2.44 | 1.81 | 0.79 | 0.89 | 1.65 | 1.39 | 0.46 | 0.25 |
| EBITDA
| 321.433 | 460.165 | 529.078 | 388.687 | 192.469 | 184.303 | 277.084 | 257.596 | 126.771 | 59.162 |
| EBITDA Ratio
| 0.134 | 0.174 | 0.189 | 0.139 | 0.111 | 0.11 | 0.151 | 0.141 | 0.082 | 0.037 |